The "minimal initial benefit" group (approximately 5-10% of users) reported limited improvements during treatment making discontinuation effects irrelevant, typically explained by inadequate product quality with degraded or low-concentration GHK-Cu, inappropriate application technique reducing absorption, unrealistic expectations exceeding what any topical can achieve, severe underlying pathology requiring medical intervention beyond cosmetic peptides, or individual non-responsiveness to copper peptide treatment for genetic or physiological reasons
This table omits the amino acids with acidic and basic side chains, in addition to cysteine and tyrosine (all of which have 3 pK a values!)
Defining post-acute COVID-19 syndrome (PACS) by an epigenetic biosignature in peripheral blood mononuclear cells
If the solution appears cloudy, discolored, or contains particles that do not dissolve after 10 minutes of gentle rolling, something has gone wrong
Does GHK-Cu Improve Fine Lines and Firmness
